Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Activation Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111892528A details a regioselective Ru-catalyzed C-H amidation method, offering cost-effective routes for high-purity pharmaceutical intermediates and scalable API manufacturing.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Patent CN111285846B details a novel Rh-catalyzed C-H activation route for 2-(2-indolyl)-acetates, offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Novel Rh-catalyzed method for trifluoromethyl enaminones. Reduces cost and improves scalability for pharmaceutical manufacturing.
Patent CN113980044B reveals a novel Ir-O-P catalyzed diboration method. This breakthrough enables cost-effective, scalable production of high-purity organoboron intermediates for drug discovery.
Novel Rh-catalyzed C-H activation for trifluoromethyl enaminones. High purity pharmaceutical intermediates with scalable cost reduction.
Discover a novel one-step C-H activation method for 3-acylated indoles. This patent-pending route offers mild conditions and high yields for pharmaceutical intermediates.
Patent CN113620795B details a novel Rh-catalyzed route to benzocycloheptenones. Discover cost-effective API intermediate manufacturing with high scalability.
Novel Ru-catalyzed C-H activation method for benzindole derivatives offers mild conditions and green solvents, ensuring reliable supply chain and cost efficiency.
Patent CN113735756A details a mild Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and cost-effective manufacturing solutions.
Patent CN113980044B details a novel Ir-O-P catalyzed C-H borylation method offering high yields and broad substrate scope for pharmaceutical intermediates.
Patent CN114181168A enables efficient synthesis of high-purity benzothiazinone intermediates with enhanced supply chain reliability and cost savings.
Discover cost-effective, high-yield synthesis of trifluoromethyl benzo[1,8]naphthyridine for OLEDs. Reduce raw material costs by 30-40% with scalable CDMO solutions.
Discover how recent patent breakthroughs in metal-free catalysis for branched 1,4-dienamide synthesis can reduce production costs and improve supply chain stability for pharmaceutical intermediates.
Discover how rhodium-catalyzed C-H activation enables cost-effective, gram-scale production of trifluoromethylated indole intermediates with high functional group tolerance for drug development.
Discover how novel C-H activation methods for polysubstituted isoquinolines reduce catalyst costs and improve yield in pharmaceutical synthesis. Contact us for custom manufacturing.
Struggling with low yields in indanone synthesis? Discover the latest Rh-catalyzed one-step method for high-purity 2-substituted indanones. Find reliable suppliers for API intermediates.